Kathleen Maxian has advanced-stage ovarian cancer that could have been prevented. When Myriad Genetics patented the two genes associated with breast and ovarian cancer they put Kathleen and thousands like her at risk.

mytubethumb play
%3Cobject%20style%3D%22height%3A%20390px%3B%20width%3A%20640px%22%20allow%3D%22autoplay%22%3E%3Cparam%20name%3D%22movie%22%20value%3D%22http%3A%2F%2Fwww.youtube.com%2Fv%2Fx2cooX57rXA%3Fversion%3D3%26amp%3Bfeature%3Dplayer_profilepage%26autoplay%3D1%26version%3D3%26playsinline%3D1%22%3E%3Cparam%20name%3D%22allowFullScreen%22%20value%3D%22true%22%3E%3Cparam%20name%3D%22allowScriptAccess%22%20value%3D%22always%22%3E%3Cembed%20allowfullscreen%3D%22true%22%20allowscriptaccess%3D%22always%22%20height%3D%22360%22%20src%3D%22http%3A%2F%2Fwww.youtube.com%2Fv%2Fx2cooX57rXA%3Fversion%3D3%26amp%3Bfeature%3Dplayer_profilepage%26autoplay%3D1%26version%3D3%26playsinline%3D1%22%20type%3D%22application%2Fx-shockwave-flash%22%20width%3D%22640%22%3E%3C%2Fembed%3E%3C%2Fobject%3E
Privacy statement. This embed will serve content from youtube.com.


A U.S. Court of Appeals has granted companies the right to patent genes, but the Supreme Court is now reviewing a petition to hear the case submitted by the ACLU and the Public Patent Foundation on behalf of plaintiffs.

Help us stop gene patenting.  Learn more: https://www.aclu.org/take-back-your-genes